BLUE BELL, Pa., Sept. 27, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has entered into a Cooperative Research and
http://www.abnnewswire.net/rss2/menafn/abn_menafn_en.asp General Mining Corporation Limited (ASX:GMM) has signed an agreement to acquire a 100% interest in a 19.6 km2 exploration licence ...
For someone who has worked diligently for over a decade to accelerate access to new life-saving pneumonia vaccines, announcements like this week's make it all seem worth it.
SAN DIEGO, Sept. 27, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has released a white paper entitled: "A Medical Devic